Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06950138Phase 3Completed
Phase 3, randomised, triple-blind trial in obesity and vascular dysfunction, sponsored by Coordinación de Investigación en Salud. Primary endpoints: Wave Pulse Velocity at 12 weeks and Flow-mediated dilatation at 12 weeks. Started Jan 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06950138.